Requires the prominent labeling of prescription and over-the- counter drugs and pharmaceuticals whose effectiveness or potency becomes diminished after storage as to the date beyond which the product shall not be used.
Authorizes the Food and Drug Administration to establish the "beyond use" dates for all applicable products, and the manner in which they shall be labeled.
Introduced in House
Introduced in House
Referred to House Committee on Interstate and Foreign Commerce.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line